this page only  
Join BIO   |   Member Directory   |    Contact BIO    
Biotechnology Industry Organization
Bio Photo

Home
About BIO
Conferences & Events
Past BIO Events
Industry Calendar
State/Int'l Calendar
Members.BIO.org
BIO News Online
BIO Bulletins
Suggestion Box
Membership Directory
BIO Videos
News & Media
BIO Blogs & Podcasts
National Issues
Health
Food & Agriculture
Industrial & Environmental
Bioethics
• Intellectual Property
Regulatory
Tax & Financial
State & Local Issues
State by State Initiatives
Letters, Testimony & Comments
Speeches & Publications
Industry At-a-Glance
Business & Finance


Tuesday, October 14, 2008

Primer

Click here for a printer-friendly page Printer Friendly YES
What are some of the great patent fights?

One of the largest patent battles in U.S. history resulted when Polaroid sued Eastman Kodak for infringement of its patents covering instant photography cameras. In 1990 Polaroid secured a $925 million judgment against Eastman Kodak.

Biotechnology is not immune to patent disputes. Two major patent court cases involved erythropoietin (EPO) and an enzyme, taq polymerase, used in a widely employed analytical technique. The first case, concluded in 1996, involved Amgen and Genetics Institute. The court ruled that Genetics Institute could not sell its version of EPO in the United States, giving Amgen a legal monopoly over the sale of EPO to kidney dialysis patients. The second case involved Hoffmann-La Roche and Promega Corporation. In this case which is still under appeal at the writing of this document, the court invalidated a patent covering taq polymerase, which is used in the polymerase chain reaction method of amplifying DNA.

Most disputes about patent claims are settled amicably with licensing or cross-licensing agreements. Companies generally prefer to avoid the expense and time that litigation entails.

© 2008 | Biotechnology Industry Organization | 1201 Maryland Ave., SW, Ste. 900 | Washington, D.C. 20024